This project is one of six projects supported through the 2026 Advancing Groundbreaking Research in Alzheimer’s and Parkinson’s Diseases – Team Award. Meet the research team members.
This funding opportunity is made possible by the Canada Brain Research Fund (CBRF), an innovative arrangement between the Government of Canada (through Health Canada) and the Brain Canada Foundation, in partnership with the Alzheimer Society of BC and Yukon, Branch Out Neurological Foundation, CLEAR Foundation, Health Research BC, Pacific Parkinson’s Research Institute, Parkinson Society BC, and the Patrick & Dulcie Lenox Endowment.
Project summary
This BC-based research project aims to develop new, non-invasive ways to detect early signs of Alzheimer’s disease (AD) through changes in the eyes and tears. We are expanding our research to the cornea, the clear surface at the front of the eye, to determine whether corneal changes provide clues to changes occurring in the brain during AD. This work builds on our team’s previous research showing AD-associated changes in the retina, including changes involving amyloid and tau, two proteins that accumulate abnormally in the brain in AD. Together, our studies of the cornea, retina, and tears aim to better understand how changes in the eye may reflect underlying changes in the brain.
Our research will use mouse models of AD together with tear samples from people with and without biological evidence of Alzheimer’s disease. In mice, we will determine whether changes in corneal nerves, immune cells and tear molecules called microRNAs reflect changes occurring in the brain as AD progresses. We will also develop new high-resolution imaging strategies that allow us to follow corneal nerve and immune-cell changes over time, without invasive procedures. These technologies will first be developed and tested in mice, providing the foundation for their future translation to studies in people.
Our long-term goal is to combine information from the retina, cornea and tears with emerging blood-based tests for AD. Bringing together different clues from the eyes, tears and blood could provide a more complete picture of the disease and enable earlier and more accurate detection, while making testing safer, more accessible and easier to repeat.
Persons with Lived Experience will help shape research priorities, participant materials, interpretation of findings and communication of results, helping ensure that the research addresses what matters to people affected by AD and their families.
Team members
Sonia Yeung
Role: Co-PI
Department: Ophthalmology
Position: Clinical Associate Professor
Myeong Jin Ju
Role: Co-PI
Department: Ophthalmology
Position: Assistant Professor




